{"count": 131, "results": [{"_id": "32767644", "pmid": 32767644, "pmcid": "PMC7521315", "title": "Chronopharmacology of simvastatin on hyperlipidaemia in high-fat diet-fed obese mice", "journal": "J Cell Mol Med", "authors": ["Li H", "Rabearivony A", "Zhang W", "Chen S", "An X", "Liu C"], "date": "2020-09-01T00:00:00Z", "doi": "10.1111/jcmm.15709", "meta_date_publication": "2020 Sep", "meta_volume": "24", "meta_issue": "18", "meta_pages": "11024-11029", "score": 50249.38, "text_hl": "The chronopharmacology refers to the utilization of physiological circadian rhythms to optimize the administration time of drugs, thus increasing their efficacy and safety, or reducing adverse effects. @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ is one of the most widely prescribed drugs for the treatment of hypercholesterolaemia, @DISEASE_Hyperlipidemias @DISEASE_MESH:D006949 @@@hyperlipidemia@@@ and @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary artery disease@@@. ", "citations": {"NLM": "Li H, Rabearivony A, Zhang W, Chen S, An X, Liu C. Chronopharmacology of simvastatin on hyperlipidaemia in high-fat diet-fed obese mice J Cell Mol Med. 2020 Sep;24(18):11024-11029. PMID: 32767644", "BibTeX": "@article{32767644, title={Chronopharmacology of simvastatin on hyperlipidaemia in high-fat diet-fed obese mice}, author={Li H and Rabearivony A and Zhang W and Chen S and An X and Liu C}, journal={J Cell Mol Med}, volume={24}, number={18}, pages={11024-11029}}"}}, {"_id": "33497862", "pmid": 33497862, "title": "LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial.", "journal": "Atherosclerosis", "authors": ["Vallejo-Vaz AJ", "Packard CJ", "Ference BA", "Santos RD", "Kastelein JJP", "Stein EA", "Catapano AL", "Pedersen TR", "Watts GF", "Ray KK"], "date": "2021-03-01T00:00:00Z", "doi": "10.1016/j.atherosclerosis.2021.01.003", "meta_date_publication": "2021 Mar", "meta_volume": "320", "meta_issue": "", "meta_pages": "1-9", "score": 50249.36, "text_hl": "METHODS: The 4S trial randomized @DISEASE_Hyperlipoproteinemia_Type_II @DISEASE_MESH:D006938 @@@hypercholesterolemic@@@ @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@ @SPECIES_9606 @@@patients@@@ to @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ or placebo. ", "citations": {"NLM": "Vallejo-Vaz AJ, Packard CJ, Ference BA, Santos RD, Kastelein JJP, Stein EA, Catapano AL, Pedersen TR, Watts GF, Ray KK. LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial. Atherosclerosis. 2021 Mar;320():1-9. PMID: 33497862", "BibTeX": "@article{33497862, title={LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial.}, author={Vallejo-Vaz AJ and Packard CJ and Ference BA and Santos RD and Kastelein JJP and Stein EA and Catapano AL and Pedersen TR and Watts GF and Ray KK}, journal={Atherosclerosis}, volume={320}, pages={1-9}}"}}, {"_id": "34785535", "pmid": 34785535, "title": "Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial.", "journal": "Diabetes Care", "authors": ["Warren RA", "Carew AS", "Andreou P", "Herman C", "Levy AP", "Ginsberg HN", "Sapp J", "Rimm EB", "Kirkland S", "Cahill LE"], "date": "2022-01-01T00:00:00Z", "doi": "10.2337/dc21-1429", "meta_date_publication": "2022 Jan 1", "meta_volume": "45", "meta_issue": "1", "meta_pages": "241-250", "score": 50246.21, "text_hl": "CONCLUSIONS: The effect of @CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@ added to @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on risk of @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@ events depends on Hp phenotype in the ACCORD @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ trial.", "citations": {"NLM": "Warren RA, Carew AS, Andreou P, Herman C, Levy AP, Ginsberg HN, Sapp J, Rimm EB, Kirkland S, Cahill LE. Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial. Diabetes Care. 2022 Jan 1;45(1):241-250. PMID: 34785535", "BibTeX": "@article{34785535, title={Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid Trial.}, author={Warren RA and Carew AS and Andreou P and Herman C and Levy AP and Ginsberg HN and Sapp J and Rimm EB and Kirkland S and Cahill LE}, journal={Diabetes Care}, volume={45}, number={1}, pages={241-250}}"}}, {"_id": "32468428", "pmid": 32468428, "pmcid": "PMC7320066", "title": "Treatment Patterns of Lipid-Lowering Therapy in Patients with Coronary Artery Disease Aged Above and Below 75 Years: A Retrospective Cross-Sectional Study of 1500 Patients in a Tertiary Care Referral Center in Germany", "journal": "Drugs Aging", "authors": ["Dykun I", "Wiefhoff D", "Totzeck M", "Al-Rashid F", "Jánosi RA", "Hendricks S", "Rassaf T", "Mahabadi AA"], "date": "2020-07-01T00:00:00Z", "doi": "10.1007/s40266-020-00768-9", "meta_date_publication": "2020 Jul", "meta_volume": "37", "meta_issue": "7", "meta_pages": "521-527", "score": 50243.508, "text_hl": "@<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@ @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary artery disease@@@, SD standard deviation", "citations": {"NLM": "Dykun I, Wiefhoff D, Totzeck M, Al-Rashid F, Jánosi RA, Hendricks S, Rassaf T, Mahabadi AA. Treatment Patterns of Lipid-Lowering Therapy in Patients with Coronary Artery Disease Aged Above and Below 75 Years: A Retrospective Cross-Sectional Study of 1500 Patients in a Tertiary Care Referral Center in Germany Drugs Aging. 2020 Jul;37(7):521-527. PMID: 32468428", "BibTeX": "@article{32468428, title={Treatment Patterns of Lipid-Lowering Therapy in Patients with Coronary Artery Disease Aged Above and Below 75 Years: A Retrospective Cross-Sectional Study of 1500 Patients in a Tertiary Care Referral Center in Germany}, author={Dykun I and Wiefhoff D and Totzeck M and Al-Rashid F and Jánosi RA and Hendricks S and Rassaf T and Mahabadi AA}, journal={Drugs Aging}, volume={37}, number={7}, pages={521-527}}"}}, {"_id": "24684779", "pmid": 24684779, "pmcid": "PMC3974153", "title": "Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome", "journal": "Diabetol Metab Syndr", "authors": ["Grosso AF", "de Oliveira SF", "Higuchi Mde L", "Favarato D", "Dallan LA", "da Luz PL"], "date": "2014-03-31T00:00:00Z", "doi": "10.1186/1758-5996-6-47", "meta_date_publication": "2014 Mar 31", "meta_volume": "6", "meta_issue": "1", "meta_pages": "47", "score": 50077.83, "text_hl": "This study assessed the anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ actions of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@ on EAT in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary artery disease@@@ (@<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@) and @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@metabolic syndrome@@@ (@DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@MS@@@).", "citations": {"NLM": "Grosso AF, de Oliveira SF, Higuchi Mde L, Favarato D, Dallan LA, da Luz PL. Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome Diabetol Metab Syndr. 2014 Mar 31;6(1):47. PMID: 24684779", "BibTeX": "@article{24684779, title={Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome}, author={Grosso AF and de Oliveira SF and Higuchi Mde L and Favarato D and Dallan LA and da Luz PL}, journal={Diabetol Metab Syndr}, volume={6}, number={1}, pages={47}}"}}, {"_id": "9480401", "pmid": 9480401, "title": "[Economic analysis of secondary prevention of coronary heart disease with simvastatin (Zocor) in Germany].", "journal": "Med Klin (Munich)", "authors": ["Obermann K", "Mattias Graf", "Schulenburg JM", "Mautner GC"], "date": "1997-11-15T00:00:00Z", "doi": "10.1007/BF03044827", "meta_date_publication": "1997 Nov 15", "meta_volume": "92", "meta_issue": "11", "meta_pages": "686-94", "score": 50074.824, "text_hl": "The 4S Study has demonstrated the clinical effectiveness in the secondary prevention of @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@. METHOD: Based on the health economics data of this study, we undertook a cost-effectiveness analysis of the secondary prevention of @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@ with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in Germany. ", "citations": {"NLM": "Obermann K, Mattias Graf, Schulenburg JM, Mautner GC. [Economic analysis of secondary prevention of coronary heart disease with simvastatin (Zocor) in Germany]. Med Klin (Munich). 1997 Nov 15;92(11):686-94. PMID: 9480401", "BibTeX": "@article{9480401, title={[Economic analysis of secondary prevention of coronary heart disease with simvastatin (Zocor) in Germany].}, author={Obermann K and Mattias Graf and Schulenburg JM and Mautner GC}, journal={Med Klin (Munich)}, volume={92}, number={11}, pages={686-94}}"}}, {"_id": "21334753", "pmid": 21334753, "title": "Pleiotropic effects of ezetimibe/simvastatin vs. high dose simvastatin.", "journal": "Int J Cardiol", "authors": ["Pesaro AE", "Serrano CV Jr", "Fernandes JL", "Cavalcanti AB", "Campos AH", "Martins HS", "Maranhão RC", "de Lemos JA", "Souza HP", "Nicolau JC"], "date": "2012-07-26T00:00:00Z", "doi": "10.1016/j.ijcard.2011.01.062", "meta_date_publication": "2012 Jul 26", "meta_volume": "158", "meta_issue": "3", "meta_pages": "400-4", "score": 50072.523, "text_hl": "BACKGROUND: In the setting of stable @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary artery disease@@@ (@<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@), it is not known if the pleiotropic effects of @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ reduction differ between combined @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@/@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and high-dose @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ alone. ", "citations": {"NLM": "Pesaro AE, Serrano CV Jr, Fernandes JL, Cavalcanti AB, Campos AH, Martins HS, Maranhão RC, de Lemos JA, Souza HP, Nicolau JC. Pleiotropic effects of ezetimibe/simvastatin vs. high dose simvastatin. Int J Cardiol. 2012 Jul 26;158(3):400-4. PMID: 21334753", "BibTeX": "@article{21334753, title={Pleiotropic effects of ezetimibe/simvastatin vs. high dose simvastatin.}, author={Pesaro AE and Serrano CV Jr and Fernandes JL and Cavalcanti AB and Campos AH and Martins HS and Maranhão RC and de Lemos JA and Souza HP and Nicolau JC}, journal={Int J Cardiol}, volume={158}, number={3}, pages={400-4}}"}}, {"_id": "15238460", "pmid": 15238460, "title": "Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study.", "journal": "Circulation", "authors": ["Jensen LO", "Thayssen P", "Pedersen KE", "Stender S", "Haghfelt T"], "date": "2004-07-20T00:00:00Z", "doi": "10.1161/01.CIR.0000135215.75876.41", "meta_date_publication": "2004 Jul 20", "meta_volume": "110", "meta_issue": "3", "meta_pages": "265-70", "score": 50071.89, "text_hl": "Regression of @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary atherosclerosis@@@ by @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@: a serial intravascular ultrasound study.", "citations": {"NLM": "Jensen LO, Thayssen P, Pedersen KE, Stender S, Haghfelt T. Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Circulation. 2004 Jul 20;110(3):265-70. PMID: 15238460", "BibTeX": "@article{15238460, title={Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study.}, author={Jensen LO and Thayssen P and Pedersen KE and Stender S and Haghfelt T}, journal={Circulation}, volume={110}, number={3}, pages={265-70}}"}}, {"_id": "9860376", "pmid": 9860376, "title": "Coronary artery disease: the Scandinavian Simvastatin Survival Study experience.", "journal": "Am J Cardiol", "authors": ["Pedersen TR"], "date": "1998-11-26T00:00:00Z", "doi": "10.1016/s0002-9149(98)00727-9", "meta_date_publication": "1998 Nov 26", "meta_volume": "82", "meta_issue": "10B", "meta_pages": "53T-56T", "score": 50071.79, "text_hl": "@<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@Coronary artery disease@@@: the Scandinavian @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Survival Study experience.", "citations": {"NLM": "Pedersen TR. Coronary artery disease: the Scandinavian Simvastatin Survival Study experience. Am J Cardiol. 1998 Nov 26;82(10B):53T-56T. PMID: 9860376", "BibTeX": "@article{9860376, title={Coronary artery disease: the Scandinavian Simvastatin Survival Study experience.}, author={Pedersen TR}, journal={Am J Cardiol}, volume={82}, number={10B}, pages={53T-56T}}"}}, {"_id": "23739650", "pmid": 23739650, "title": "Increasing doses of simvastatin versus combined ezetimibe/simvastatin: effect on circulating endothelial progenitor cells.", "journal": "J Cardiovasc Pharmacol Ther", "authors": ["Pesaro AE", "Serrano CV Jr", "Katz M", "Marti L", "Fernandes JL", "Parra PR", "Campos AH"], "date": "2013-09-01T00:00:00Z", "doi": "10.1177/1074248413489771", "meta_date_publication": "2013 Sep", "meta_volume": "18", "meta_issue": "5", "meta_pages": "447-52", "score": 50069.57, "text_hl": "OBJECTIVE: We sought to compare, in @SPECIES_9606 @@@patients@@@ with stable @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@ and with a low-density lipoprotein cholesterol (LDL-C) >70 mg/dL on treatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 20 mg, the effects on EPCs by increasing @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ to 80 mg versus adding ezetimibe 10 mg. ", "citations": {"NLM": "Pesaro AE, Serrano CV Jr, Katz M, Marti L, Fernandes JL, Parra PR, Campos AH. Increasing doses of simvastatin versus combined ezetimibe/simvastatin: effect on circulating endothelial progenitor cells. J Cardiovasc Pharmacol Ther. 2013 Sep;18(5):447-52. PMID: 23739650", "BibTeX": "@article{23739650, title={Increasing doses of simvastatin versus combined ezetimibe/simvastatin: effect on circulating endothelial progenitor cells.}, author={Pesaro AE and Serrano CV Jr and Katz M and Marti L and Fernandes JL and Parra PR and Campos AH}, journal={J Cardiovasc Pharmacol Ther}, volume={18}, number={5}, pages={447-52}}"}}]}